Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 333 articles:
HTML format
Text format



Single Articles


    January 2017
  1. ZHANG Y, Xue Q, Pan G, Meng QH, et al
    Integrated Analysis of Genome-Wide Copy Number Alterations and Gene Expression Profiling of Lung Cancer in Xuanwei, China.
    PLoS One. 2017;12:e0169098.
    PubMed     Text format     Abstract available


  2. HUYNH E, Coroller TP, Narayan V, Agrawal V, et al
    Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
    PLoS One. 2017;12:e0169172.
    PubMed     Text format     Abstract available


  3. BEN-LULU S, Ziv T, Weisman-Shomer P, Benhar M, et al
    Nitrosothiol-Trapping-Based Proteomic Analysis of S-Nitrosylation in Human Lung Carcinoma Cells.
    PLoS One. 2017;12:e0169862.
    PubMed     Text format     Abstract available


  4. XIAO L, Liu N, Zhang G, Zhang H, et al
    Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
    PLoS One. 2017;12:e0170901.
    PubMed     Text format     Abstract available


  5. LOKK K, Vooder T, Kolde R, Valk K, et al
    Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer.
    PLoS One. 2017;12:e0170833.
    PubMed     Text format     Abstract available


  6. NATTENMULLER J, Wochner R, Muley T, Steins M, et al
    Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.
    PLoS One. 2017;12:e0169136.
    PubMed     Text format     Abstract available


  7. TAKASE Y, Usui K, Shimizu K, Kimura Y, et al
    Highly sensitive detection of a HER2 12-base pair duplicated insertion mutation in lung cancer using the Eprobe-PCR method.
    PLoS One. 2017;12:e0171225.
    PubMed     Text format     Abstract available


  8. HOU LK, Ma YS, Han Y, Lu GX, et al
    Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.
    PLoS One. 2017;12:e0170431.
    PubMed     Text format     Abstract available


  9. WALKER R, Deppen S, Smith G, Shi C, et al
    68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
    PLoS One. 2017;12:e0171301.
    PubMed     Text format     Abstract available


  10. TSUCHIYA N, Doai M, Usuda K, Uramoto H, et al
    Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion.
    PLoS One. 2017;12:e0172433.
    PubMed     Text format     Abstract available


  11. AOKI N, Mochizuki K, Matsui Y
    DNA methylation of the Fthl17 5'-upstream region regulates differential Fthl17 expression in lung cancer cells and germline stem cells.
    PLoS One. 2017;12:e0172219.
    PubMed     Text format     Abstract available


  12. CHEN Y, Min L, Ren C, Xu X, et al
    miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.
    PLoS One. 2017;12:e0171751.
    PubMed     Text format     Abstract available


  13. SUDA K, Rozeboom L, Yu H, Ellison K, et al
    Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.
    PLoS One. 2017;12:e0172209.
    PubMed     Text format     Abstract available


  14. HRADILOVA N, Sadilkova L, Palata O, Mysikova D, et al
    Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
    PLoS One. 2017;12:e0171539.
    PubMed     Text format     Abstract available


  15. SOK SP, Arshad NM, Azmi MN, Awang K, et al
    The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.
    PLoS One. 2017;12:e0171329.
    PubMed     Text format     Abstract available


  16. KAWAZOE H, Yano A, Ishida Y, Takechi K, et al
    Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study.
    PLoS One. 2017;12:e0171066.
    PubMed     Text format     Abstract available


  17. HUNG MS, Chen IC, Lee CP, Huang RJ, et al
    Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study.
    PLoS One. 2017;12:e0171137.
    PubMed     Text format     Abstract available


  18. JIAO DM, Yan L, Wang LS, Hu HZ, et al
    Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
    PLoS One. 2017;12:e0172470.
    PubMed     Text format     Abstract available


  19. NARITA M, Shimura E, Nagasawa A, Aiuchi T, et al
    Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.
    PLoS One. 2017;12:e0172115.
    PubMed     Text format     Abstract available


  20. SHEN G, Lan Y, Zhang K, Ren P, et al
    Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
    PLoS One. 2017;12:e0173104.
    PubMed     Text format     Abstract available


  21. HOU PF, Zhu LJ, Chen XY, Qiu ZQ, et al
    Age-related changes in CD4+CD25+FOXP3+ regulatory T cells and their relationship with lung cancer.
    PLoS One. 2017;12:e0173048.
    PubMed     Text format     Abstract available


  22. HORIBE R, Hirohashi Y, Asano T, Mariya T, et al
    Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.
    PLoS One. 2017;12:e0171460.
    PubMed     Text format     Abstract available


  23. SHIN DW, Kim YI, Kim SJ, Kim JS, et al
    Lung cancer specialist physicians' attitudes towards e-cigarettes: A nationwide survey.
    PLoS One. 2017;12:e0172568.
    PubMed     Text format     Abstract available


  24. YIN J, Zhao J, Hu W, Yang G, et al
    Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.
    PLoS One. 2017;12:e0172787.
    PubMed     Text format     Abstract available


  25. SHEEHAN DF, Criss SD, Gazelle GS, Pandharipande PV, et al
    Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach.
    PLoS One. 2017;12:e0173119.
    PubMed     Text format     Abstract available


  26. ROSENBERGER A, Sohns M, Friedrichs S, Hung RJ, et al
    Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.
    PLoS One. 2017;12:e0173339.
    PubMed     Text format     Abstract available


  27. YANG Y, Qiu S, Qian L, Tian Y, et al
    OCF can repress tumor metastasis by inhibiting epithelial-mesenchymal transition involved in PTEN/PI3K/AKT pathway in lung cancer cells.
    PLoS One. 2017;12:e0174021.
    PubMed     Text format     Abstract available


    January 2016
  28. LOHINAI Z, Dome P, Szilagyi Z, Ostoros G, et al
    From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC).
    PLoS One. 2016;11:e0144797.
    PubMed     Text format     Abstract available


  29. GUERRERA F, Tabbo F, Bessone L, Maletta F, et al
    The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.
    PLoS One. 2016;11:e0145100.
    PubMed     Text format     Abstract available


  30. LIU J, Dong M, Sun X, Li W, et al
    Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0146195.
    PubMed     Text format     Abstract available


  31. HAGEDOORN P, Vandenheede H, Willaert D, Vanthomme K, et al
    Regional Inequalities in Lung Cancer Mortality in Belgium at the Beginning of the 21st Century: The Contribution of Individual and Area-Level Socioeconomic Status and Industrial Exposure.
    PLoS One. 2016;11:e0147099.
    PubMed     Text format     Abstract available


  32. YANG Y, Nguyen TT, Jeong MH, Crisan F, et al
    Inhibitory Activity of (+)-Usnic Acid against Non-Small Cell Lung Cancer Cell Motility.
    PLoS One. 2016;11:e0146575.
    PubMed     Text format     Abstract available


  33. YOSHIDA T, Song L, Bai Y, Kinose F, et al
    ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0147344.
    PubMed     Text format     Abstract available


  34. QIU ZX, Sun RF, Mo XM, Li WM, et al
    The p70S6K Specific Inhibitor PF-4708671 Impedes Non-Small Cell Lung Cancer Growth.
    PLoS One. 2016;11:e0147185.
    PubMed     Text format     Abstract available


  35. MEREDITH SL, Bryant JL, Babur M, Riddell PW, et al
    Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.
    PLoS One. 2016;11:e0148404.
    PubMed     Text format     Abstract available


  36. HU M, Hu Y, He J, Li B, et al
    Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.
    PLoS One. 2016;11:e0147374.
    PubMed     Text format     Abstract available


  37. LI W, Wang Y, Zhang Q, Tang L, et al
    Correction: MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0148589.
    PubMed     Text format     Abstract available


  38. AVILA-MORENO F, Armas-Lopez L, Alvarez-Moran AM, Lopez-Bujanda Z, et al
    Correction: Overexpression of MEOX2 and TWIST1 is Associated with H3K27me3 Levels and Determines Lung Cancer Chemoresistance and Prognosis.
    PLoS One. 2016;11:e0146569.
    PubMed     Text format     Abstract available


  39. MALANGA D, Belmonte S, Colelli F, Scarfo M, et al
    AKT1E17K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer.
    PLoS One. 2016;11:e0147334.
    PubMed     Text format     Abstract available


  40. LUI NS, Yang YW, van Zante A, Buchanan P, et al
    SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.
    PLoS One. 2016;11:e0148911.
    PubMed     Text format     Abstract available


  41. KHAN S, Imran A, Khan AA, Abul Kalam M, et al
    Systems Biology Approaches for the Prediction of Possible Role of Chlamydia pneumoniae Proteins in the Etiology of Lung Cancer.
    PLoS One. 2016;11:e0148530.
    PubMed     Text format     Abstract available


  42. CHEN YM, Lai CH, Chang HC, Chao TY, et al
    Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    PLoS One. 2016;11:e0149722.
    PubMed     Text format     Abstract available


  43. CHANG WH, Ho BC, Hsiao YJ, Chen JS, et al
    JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer.
    PLoS One. 2016;11:e0150355.
    PubMed     Text format     Abstract available


  44. CHENG NM, Fang YH, Tsan DL, Hsu CH, et al
    Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer Patients.
    PLoS One. 2016;11:e0150509.
    PubMed     Text format     Abstract available


  45. SHERWOOD JL, Corcoran C, Brown H, Sharpe AD, et al
    Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC).
    PLoS One. 2016;11:e0150197.
    PubMed     Text format     Abstract available


  46. BAYARRI-LARA C, Ortega FG, Cueto Ladron de Guevara A, Puche JL, et al
    Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
    PLoS One. 2016;11:e0148659.
    PubMed     Text format     Abstract available


  47. HOWE GA, Xiao B, Zhao H, Al-Zahrani KN, et al
    Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0150567.
    PubMed     Text format     Abstract available


  48. REGAN E, Sibley RC, Cenik BK, Silva A, et al
    Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines.
    PLoS One. 2016;11:e0150963.
    PubMed     Text format     Abstract available


  49. BAI XY, Zhang XC, Yang SQ, An SJ, et al
    Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
    PLoS One. 2016;11:e0149370.
    PubMed     Text format     Abstract available


  50. ZHANG Y, Jiang M, Li Q, Liang W, et al
    Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.
    PLoS One. 2016;11:e0149946.
    PubMed     Text format     Abstract available


  51. LEUNG AW, Hung SS, Backstrom I, Ricaurte D, et al
    Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In Vitro.
    PLoS One. 2016;11:e0150675.
    PubMed     Text format     Abstract available


  52. SAITO K, Nakayama E, Valmori D
    Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
    PLoS One. 2016;11:e0150623.
    PubMed     Text format     Abstract available


  53. LI R, Pu X, Chang JY, Ye Y, et al
    MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0150467.
    PubMed     Text format     Abstract available


  54. DEDONG C, Huilin X, Anbing H, Ximing X, et al
    The Effect of ShenQi FuZheng Injection in Combination with Chemotherapy versus Chemotherapy Alone on the Improvement of Efficacy and Immune Function in Patients with Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0152270.
    PubMed     Text format     Abstract available


  55. ZHANG C, Zhang H, Shi J, Wang D, et al
    Trial-Based Cost-Utility Analysis of Icotinib versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in China.
    PLoS One. 2016;11:e0151846.
    PubMed     Text format     Abstract available


  56. ZHANG Q, Gao M, Luo G, Han X, et al
    Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the beta-Catenin/Tcf4 Interaction.
    PLoS One. 2016;11:e0152407.
    PubMed     Text format     Abstract available


  57. SABER A, van der Wekken AJ, Kerner GS, van den Berge M, et al
    Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0152317.
    PubMed     Text format     Abstract available


  58. ZHOU YY, Hu ZG, Zeng FJ, Han J, et al
    Clinical Profile of Cyclooxygenase-2 Inhibitors in Treating Non-Small Cell Lung Cancer: A Meta-Analysis of Nine Randomized Clinical Trials.
    PLoS One. 2016;11:e0151939.
    PubMed     Text format     Abstract available


  59. DE GREVE J, Van Meerbeeck J, Vansteenkiste JF, Decoster L, et al
    Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
    PLoS One. 2016;11:e0147599.
    PubMed     Text format     Abstract available


  60. LYONS JD, Mittal R, Fay KT, Chen CW, et al
    Murine Lung Cancer Increases CD4+ T Cell Apoptosis and Decreases Gut Proliferative Capacity in Sepsis.
    PLoS One. 2016;11:e0149069.
    PubMed     Text format     Abstract available


  61. CARDNELL RJ, Feng Y, Mukherjee S, Diao L, et al
    Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.
    PLoS One. 2016;11:e0152584.
    PubMed     Text format     Abstract available


  62. PARK SA, Lee JW, Herbst RS, Koo JS, et al
    GSK-3alpha Is a Novel Target of CREB and CREB-GSK-3alpha Signaling Participates in Cell Viability in Lung Cancer.
    PLoS One. 2016;11:e0153075.
    PubMed     Text format     Abstract available


  63. RAES F, Sobilo J, Le Mee M, Retif S, et al
    High Resolution Ultrasound and Photoacoustic Imaging of Orthotopic Lung Cancer in Mice: New Perspectives for Onco-Pharmacology.
    PLoS One. 2016;11:e0153532.
    PubMed     Text format     Abstract available


  64. MIYAZAKI R, Anayama T, Hirohashi K, Okada H, et al
    In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer.
    PLoS One. 2016;11:e0152665.
    PubMed     Text format     Abstract available


  65. ZHU W, Zhou K, Zha Y, Chen D, et al
    Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0153046.
    PubMed     Text format     Abstract available


  66. O SANTOS A, Parrini MC, Camonis J
    RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases.
    PLoS One. 2016;11:e0154840.
    PubMed     Text format     Abstract available


  67. KERNER GS, Koole MJ, Bongaerts AH, Pruim J, et al
    Total Body Metabolic Tumor Response in ALK Positive Non-Small Cell Lung Cancer Patients Treated with ALK Inhibition.
    PLoS One. 2016;11:e0149955.
    PubMed     Text format     Abstract available


  68. SUTIMAN N, Zhang Z, Tan EH, Ang MK, et al
    Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules.
    PLoS One. 2016;11:e0154316.
    PubMed     Text format     Abstract available


  69. TSENG CY, Lin CH, Wu LY, Wang JS, et al
    Potential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and Cisplatin.
    PLoS One. 2016;11:e0155469.
    PubMed     Text format     Abstract available


  70. JIN KN, Sung YW, Oh SJ, Choi YR, et al
    Association between Image Characteristics on Chest CT and Severe Pleural Adhesion during Lung Cancer Surgery.
    PLoS One. 2016;11:e0154694.
    PubMed     Text format     Abstract available


  71. GAO C, Shen Y, Jin F, Miao Y, et al
    Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
    PLoS One. 2016;11:e0154576.
    PubMed     Text format     Abstract available


  72. CARDONA AF, Rojas L, Wills B, Arrieta O, et al
    Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression.
    PLoS One. 2016;11:e0154293.
    PubMed     Text format     Abstract available


  73. BODNAR M, Guerrero P, Perez-Carrasco R, Piotrowska MJ, et al
    Deterministic and Stochastic Study for a Microscopic Angiogenesis Model: Applications to the Lewis Lung Carcinoma.
    PLoS One. 2016;11:e0155553.
    PubMed     Text format     Abstract available


  74. LIU XQ, Kiefl R, Roskopf C, Tian F, et al
    Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression.
    PLoS One. 2016;11:e0156268.
    PubMed     Text format     Abstract available


  75. ZHU L, Zhang S, Xu X, Wang B, et al
    Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review.
    PLoS One. 2016;11:e0156494.
    PubMed     Text format     Abstract available


  76. SALTYBAEVA N, Martini K, Frauenfelder T, Alkadhi H, et al
    Organ Dose and Attributable Cancer Risk in Lung Cancer Screening with Low-Dose Computed Tomography.
    PLoS One. 2016;11:e0155722.
    PubMed     Text format     Abstract available


  77. PATEL YM, Park SL, Carmella SG, Paiano V, et al
    Metabolites of the Polycyclic Aromatic Hydrocarbon Phenanthrene in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
    PLoS One. 2016;11:e0156203.
    PubMed     Text format     Abstract available


  78. ZHAO J, Xia Y, Kaminski J, Hao Z, et al
    Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies.
    PLoS One. 2016;11:e0157455.
    PubMed     Text format     Abstract available


  79. ENEWOLD L, Thomas A
    Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States.
    PLoS One. 2016;11:e0156728.
    PubMed     Text format     Abstract available


  80. WEI Y, Zhao W, Huang Y, Yu Q, et al
    A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
    PLoS One. 2016;11:e0157606.
    PubMed     Text format     Abstract available


  81. DONG X, Sun X, Sun L, Maxim PG, et al
    Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0157836.
    PubMed     Text format     Abstract available


  82. GROTTKE A, Ewald F, Lange T, Norz D, et al
    Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    PLoS One. 2016;11:e0146370.
    PubMed     Text format     Abstract available


  83. HUANG Q, Wei H, Wu Z, Li L, et al
    Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis.
    PLoS One. 2016;11:e0149640.
    PubMed     Text format     Abstract available


  84. LU YC, Lee YR, Liao JD, Lin CY, et al
    Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells.
    PLoS One. 2016;11:e0158587.
    PubMed     Text format     Abstract available


  85. HUNG MS, Chen IC, Lung JH, Lin PY, et al
    Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells.
    PLoS One. 2016;11:e0158395.
    PubMed     Text format     Abstract available


  86. LI D, Shi J, Du Y, Chen K, et al
    Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment.
    PLoS One. 2016;11:e0158214.
    PubMed     Text format     Abstract available


  87. RAO Q, You A, Guo Z, Zuo B, et al
    Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.
    PLoS One. 2016;11:e0148263.
    PubMed     Text format     Abstract available


  88. ANDO K, Okada Y, Akiba M, Kondo T, et al
    Lung Transplantation for Lymphangioleiomyomatosis in Japan.
    PLoS One. 2016;11:e0146749.
    PubMed     Text format     Abstract available


  89. KOO HJ, Lee M, Kim J, Woo CW, et al
    Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.
    PLoS One. 2016;11:e0148784.
    PubMed     Text format     Abstract available


  90. KIM H, Park CM, Song YS, Sunwoo L, et al
    Measurement Variability of Persistent Pulmonary Subsolid Nodules on Same-Day Repeat CT: What Is the Threshold to Determine True Nodule Growth during Follow-Up?
    PLoS One. 2016;11:e0148853.
    PubMed     Text format     Abstract available


  91. KICIELINSKA J, Szczygiel A, Rossowska J, Anger N, et al
    Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models.
    PLoS One. 2016;11:e0148156.
    PubMed     Text format     Abstract available


  92. PAPADODIMA O, Moulos P, Koryllou A, Piroti G, et al
    Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.
    PLoS One. 2016;11:e0160248.
    PubMed     Text format    


  93. IM JS, Herrmann AC, Bernatchez C, Haymaker C, et al
    Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer.
    PLoS One. 2016;11:e0160004.
    PubMed     Text format     Abstract available


  94. SARDARO A, Saito K, Nakayama E, Valmori D, et al
    Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
    PLoS One. 2016;11:e0160538.
    PubMed     Text format     Abstract available


  95. LIU M, Feng LX, Sun P, Liu W, et al
    A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice.
    PLoS One. 2016;11:e0159789.
    PubMed     Text format     Abstract available



  96. Retraction: Association of CYP2A6*4 with Susceptibility of Lung Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0160299.
    PubMed     Text format    


  97. WANG CM, Ling ZG, Wu YB, Cai SQ, et al
    Prognostic Value of Pleural Lavage Cytology in Patients with Lung Cancer Resection: An Updated Meta-Analysis.
    PLoS One. 2016;11:e0157518.
    PubMed     Text format     Abstract available


  98. JIAN ZH, Huang JY, Lin FC, Nfor ON, et al
    Post-Inhaled Corticosteroid Pulmonary Tuberculosis Increases Lung Cancer in Patients with Asthma.
    PLoS One. 2016;11:e0159683.
    PubMed     Text format     Abstract available


  99. LI P, Zhang G, Li J, Yang R, et al
    Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma.
    PLoS One. 2016;11:e0150790.
    PubMed     Text format     Abstract available


  100. LI W, Pi X, Qiao P, Liu H, et al
    Collecting Protein Biomarkers in Breath Using Electret Filters: A Preliminary Method on New Technical Model and Human Study.
    PLoS One. 2016;11:e0150481.
    PubMed     Text format     Abstract available


  101. CADIER B, Durand-Zaleski I, Thomas D, Chevreul K, et al
    Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
    PLoS One. 2016;11:e0148750.
    PubMed     Text format     Abstract available


  102. ROONEY C, Geh C, Williams V, Heuckmann JM, et al
    Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.
    PLoS One. 2016;11:e0149628.
    PubMed     Text format     Abstract available


  103. HUANG T, Li J, Zhang C, Hong Q, et al
    Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis.
    PLoS One. 2016;11:e0149088.
    PubMed     Text format     Abstract available


  104. YUAN P, Cao JL, Abuduwufuer A, Wang LM, et al
    Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
    PLoS One. 2016;11:e0146803.
    PubMed     Text format     Abstract available


  105. LIM EA, Lee H, Bae E, Lim J, et al
    Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea.
    PLoS One. 2016;11:e0160155.
    PubMed     Text format     Abstract available


  106. HU X, Pu K, Feng X, Wen S, et al
    Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0149247.
    PubMed     Text format     Abstract available


  107. WENG TY, Wang CY, Hung YH, Chen WC, et al
    Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.
    PLoS One. 2016;11:e0161007.
    PubMed     Text format     Abstract available


  108. KUMAR A, Corey C, Scott I, Shiva S, et al
    Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0160783.
    PubMed     Text format     Abstract available


  109. LI K, Yu Y, Sun S, Liu Y, et al
    Functional Characterisation of Anticancer Activity in the Aqueous Extract of Helicteres angustifolia L. Roots.
    PLoS One. 2016;11:e0152017.
    PubMed     Text format     Abstract available


  110. FURUYA M, Tanaka R, Okudela K, Nakamura S, et al
    Pulmonary Neoplasms in Patients with Birt-Hogg-Dube Syndrome: Histopathological Features and Genetic and Somatic Events.
    PLoS One. 2016;11:e0151476.
    PubMed     Text format     Abstract available


  111. SHENG J, Yang YP, Ma YX, Qin T, et al
    Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.
    PLoS One. 2016;11:e0147226.
    PubMed     Text format     Abstract available


  112. LI BT, Lou E, Hsu M, Yu HA, et al
    Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    PLoS One. 2016;11:e0146063.
    PubMed     Text format     Abstract available


  113. DIETZ S, Schirmer U, Merce C, von Bubnoff N, et al
    Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.
    PLoS One. 2016;11:e0161012.
    PubMed     Text format     Abstract available


  114. ZHANG W, Ning N, Li X, Niu G, et al
    Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study.
    PLoS One. 2016;11:e0161325.
    PubMed     Text format     Abstract available


  115. BEN AMOR A, Beauchemin K, Faucher MC, Hamzaoui A, et al
    Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
    PLoS One. 2016;11:e0161210.
    PubMed     Text format     Abstract available


  116. REIGSTAD I, Smeland HY, Skogstrand T, Sortland K, et al
    Stromal Integrin alpha11beta1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently.
    PLoS One. 2016;11:e0151663.
    PubMed     Text format     Abstract available


  117. ARENS AI, Postema JW, Schreurs WM, Lafeber A, et al
    FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.
    PLoS One. 2016;11:e0160539.
    PubMed     Text format     Abstract available


  118. O'DOWD EL, McKeever TM, Baldwin DR, Hubbard RB, et al
    Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013.
    PLoS One. 2016;11:e0161399.
    PubMed     Text format     Abstract available


  119. KIM EY, Kim YS, Seo JY, Park I, et al
    The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer.
    PLoS One. 2016;11:e0161125.
    PubMed     Text format     Abstract available


  120. SALAMEKH S, Rong Y, Ayan AS, Mo X, et al
    Inter-Fraction Tumor Volume Response during Lung Stereotactic Body Radiation Therapy Correlated to Patient Variables.
    PLoS One. 2016;11:e0153245.
    PubMed     Text format     Abstract available


  121. KIKUTAKE C, Yahara K
    Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis.
    PLoS One. 2016;11:e0152918.
    PubMed     Text format     Abstract available


  122. GHAGHADA KB, Sato AF, Starosolski ZA, Berg J, et al
    Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.
    PLoS One. 2016;11:e0152718.
    PubMed     Text format     Abstract available


  123. PATEL P, Kato T, Ujiie H, Wada H, et al
    Multi-Modal Imaging in a Mouse Model of Orthotopic Lung Cancer.
    PLoS One. 2016;11:e0161991.
    PubMed     Text format     Abstract available


  124. HU X, He W, Wen S, Feng X, et al
    Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis.
    PLoS One. 2016;11:e0151988.
    PubMed     Text format     Abstract available


  125. CASTRO NP, Merchant AS, Saylor KL, Anver MR, et al
    Adaptation of Laser Microdissection Technique for the Study of a Spontaneous Metastatic Mammary Carcinoma Mouse Model by NanoString Technologies.
    PLoS One. 2016;11:e0153270.
    PubMed     Text format     Abstract available


  126. LIEW KL, Jee JM, Yap I, Yong PV, et al
    In Vitro Analysis of Metabolites Secreted during Infection of Lung Epithelial Cells by Cryptococcus neoformans.
    PLoS One. 2016;11:e0153356.
    PubMed     Text format     Abstract available


  127. SABER A, van der Wekken AJ, Kok K, Terpstra MM, et al
    Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing.
    PLoS One. 2016;11:e0153065.
    PubMed     Text format     Abstract available


  128. KASAI S, Arakawa N, Okubo A, Shigeeda W, et al
    NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG.
    PLoS One. 2016;11:e0153181.
    PubMed     Text format     Abstract available


  129. GRECKA E, Statkiewicz M, Gorska A, Biernacka M, et al
    Prenyl Ammonium Salts - New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
    PLoS One. 2016;11:e0153633.
    PubMed     Text format     Abstract available


  130. SEHGAL IS, Dhooria S, Gupta N, Bal A, et al
    Impact of Endobronchial Ultrasound (EBUS) Training on the Diagnostic Yield of Conventional Transbronchial Needle Aspiration for Lymph Node Stations 4R and 7.
    PLoS One. 2016;11:e0153793.
    PubMed     Text format     Abstract available


  131. NORONHA V, Ramaswamy A, Patil VM, Joshi A, et al
    ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.
    PLoS One. 2016;11:e0160752.
    PubMed     Text format     Abstract available


  132. FENG Y, Zhou J, Li Z, Jiang Y, et al
    Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study.
    PLoS One. 2016;11:e0162133.
    PubMed     Text format     Abstract available


  133. KOO HJ, Do KH, Lee JB, Alblushi S, et al
    Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0161437.
    PubMed     Text format     Abstract available


  134. ZENG Y, Ruan W, He J, Zhang J, et al
    Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0162630.
    PubMed     Text format     Abstract available


  135. FLECKENSTEIN J, Jelden M, Kremp S, Jagoda P, et al
    The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer.
    PLoS One. 2016;11:e0162816.
    PubMed     Text format     Abstract available


  136. LEE H, Kim Y, Jeong JH, Ryu JH, et al
    ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.
    PLoS One. 2016;11:e0162335.
    PubMed     Text format     Abstract available


  137. CHI A, Wen S, Monga M, Almubarak M, et al
    Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0162453.
    PubMed     Text format     Abstract available


  138. YAN F, Pang J, Peng Y, Molina JR, et al
    Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells.
    PLoS One. 2016;11:e0162925.
    PubMed     Text format     Abstract available


  139. TRAN TB, Baek C, Min J
    Electric Cell-Substrate Impedance Sensing (ECIS) with Microelectrode Arrays for Investigation of Cancer Cell-Fibroblasts Interaction.
    PLoS One. 2016;11:e0153813.
    PubMed     Text format     Abstract available


  140. KANG HJ, Hwangbo B, Lee JS, Kim MS, et al
    Comparison of Epidermal Growth Factor Receptor Mutations between Metastatic Lymph Node Diagnosed by EBUS-TBNA and Primary Tumor in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0163652.
    PubMed     Text format     Abstract available


  141. LI H, Ren Y, Xia L, Qu R, et al
    Association of MicroRNA-149 Polymorphism with Lung Cancer Risk in Chinese Non-Smoking Female: A Case-Control Study.
    PLoS One. 2016;11:e0163626.
    PubMed     Text format     Abstract available


  142. KIM EY, Kim N, Kim YS, Seo JY, et al
    Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
    PLoS One. 2016;11:e0164056.
    PubMed     Text format     Abstract available


  143. WANG J, Kalhor N, Hu J, Wang B, et al
    Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0163397.
    PubMed     Text format     Abstract available


  144. FUJITA H, Gomori A, Fujioka Y, Kataoka Y, et al
    High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.
    PLoS One. 2016;11:e0164830.
    PubMed     Text format     Abstract available


  145. WANG Z, Hu Y, Wang Y, Han W, et al
    Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0164416.
    PubMed     Text format     Abstract available


  146. LYCAN TW, Pardee TS, Petty WJ, Bonomi M, et al
    A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.
    PLoS One. 2016;11:e0164244.
    PubMed     Text format     Abstract available


  147. LIN J, Zhang Y, Wang H, Chang J, et al
    Genetic Polymorphisms in the Apoptosis-Associated Gene CASP3 and the Risk of Lung Cancer in Chinese Population.
    PLoS One. 2016;11:e0164358.
    PubMed     Text format     Abstract available


  148. ZAPOROZHCHENKO IA, Morozkin ES, Skvortsova TE, Ponomaryova AA, et al
    Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer.
    PLoS One. 2016;11:e0165261.
    PubMed     Text format     Abstract available


  149. KORRODI-GREGORIO L, Soto-Cerrato V, Vitorino R, Fardilha M, et al
    From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research.
    PLoS One. 2016;11:e0165973.
    PubMed     Text format     Abstract available


  150. WAGLAND R, Brindle L, Ewings S, James E, et al
    Promoting Help-Seeking in Response to Symptoms amongst Primary Care Patients at High Risk of Lung Cancer: A Mixed Method Study.
    PLoS One. 2016;11:e0165677.
    PubMed     Text format     Abstract available


  151. KINSEY CM, Hamlington KL, O'Toole J, Stapleton R, et al
    Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population.
    PLoS One. 2016;11:e0165471.
    PubMed     Text format     Abstract available


  152. WALTER RF, Werner R, Vollbrecht C, Hager T, et al
    ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology.
    PLoS One. 2016;11:e0165181.
    PubMed     Text format     Abstract available


  153. KRUER TL, Dougherty SM, Reynolds L, Long E, et al
    Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
    PLoS One. 2016;11:e0166363.
    PubMed     Text format     Abstract available


  154. KUNISAWA S, Fushimi K, Imanaka Y
    Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals.
    PLoS One. 2016;11:e0166269.
    PubMed     Text format     Abstract available


  155. MIYAZAKI R, Anayama T, Hirohashi K, Okada H, et al
    Correction: In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer.
    PLoS One. 2016;11:e0166505.
    PubMed     Text format     Abstract available


  156. WANG BY, Huang JY, Hung WH, Lin CH, et al
    Impact on Survival on Interval between Surgery and Adjuvant Chemotherapy in Completely Resected Stage IB-IIIA Lung Cancer.
    PLoS One. 2016;11:e0163809.
    PubMed     Text format     Abstract available


  157. MENG Q, Ren M, Li Y, Song X, et al
    LncRNA-RMRP Acts as an Oncogene in Lung Cancer.
    PLoS One. 2016;11:e0164845.
    PubMed     Text format     Abstract available



  158. Correction: ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.
    PLoS One. 2016;11:e0168221.
    PubMed     Text format     Abstract available


  159. CHEN YM, Fang YT, Lai CH, Rau KM, et al
    A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases.
    PLoS One. 2016;11:e0167923.
    PubMed     Text format     Abstract available


  160. HELLWIG B, Madjar K, Edlund K, Marchan R, et al
    Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy.
    PLoS One. 2016;11:e0167585.
    PubMed     Text format     Abstract available


  161. PRICE DN, McBride AA, Anton M, Kusewitt DF, et al
    Longitudinal Assessment of Lung Cancer Progression in Mice Using the Sodium Iodide Symporter Reporter Gene and SPECT/CT Imaging.
    PLoS One. 2016;11:e0169107.
    PubMed     Text format     Abstract available


  162. SUN L, Liu X, Fu H, Zhou W, et al
    2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells.
    PLoS One. 2016;11:e0168793.
    PubMed     Text format     Abstract available


  163. FUJIMOTO D, Kato R, Morimoto T, Shimizu R, et al
    Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer.
    PLoS One. 2016;11:e0168465.
    PubMed     Text format     Abstract available


  164. LAI X, Friedman A
    Exosomal miRs in Lung Cancer: A Mathematical Model.
    PLoS One. 2016;11:e0167706.
    PubMed     Text format     Abstract available


  165. WEI WE, Mao NQ, Ning SF, Li JL, et al
    An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, China.
    PLoS One. 2016;11:e0168795.
    PubMed     Text format     Abstract available


  166. AMERATUNGA M, Asadi K, Lin X, Walkiewicz M, et al
    PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.
    PLoS One. 2016;11:e0153954.
    PubMed     Text format     Abstract available


    January 2015
  167. PAN CC, Kung PT, Wang YH, Chang YC, et al
    Effects of multidisciplinary team care on the survival of patients with different stages of non-small cell lung cancer: a national cohort study.
    PLoS One. 2015;10:e0126547.
    PubMed     Text format     Abstract available


  168. WOZNIAK MB, Scelo G, Muller DC, Mukeria A, et al
    Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
    PLoS One. 2015;10:e0125026.
    PubMed     Text format     Abstract available


  169. XU H, Sun H, Zhang H, Liu J, et al
    An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.
    PLoS One. 2015;10:e0124033.
    PubMed     Text format     Abstract available


  170. CSANADI A, Kayser C, Donauer M, Gumpp V, et al
    Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly.
    PLoS One. 2015;10:e0126357.
    PubMed     Text format     Abstract available


  171. WANG DD, Ma L, Wong MP, Lee VH, et al
    Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments.
    PLoS One. 2015;10:e0128360.
    PubMed     Text format     Abstract available


  172. BLANCO-PRIETO S, Vazquez-Iglesias L, Rodriguez-Girondo M, Barcia-Castro L, et al
    Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer.
    PLoS One. 2015;10:e0127318.
    PubMed     Text format     Abstract available


  173. WANG HL, Wang SS, Song WH, Pan Y, et al
    Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance.
    PLoS One. 2015;10:e0125924.
    PubMed     Text format     Abstract available


  174. ZHAO X, Wang S, Wu J, Li X, et al
    Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.
    PLoS One. 2015;10:e0129232.
    PubMed     Text format     Abstract available


  175. LI Y, Yao Y, Qian X, Shi L, et al
    The Association of Adiponectin Gene Promoter Variations with Non-Small Cell Lung Cancer in a Han Chinese Population.
    PLoS One. 2015;10:e0127751.
    PubMed     Text format     Abstract available


  176. FUJIWARA K, Koyama K, Suga K, Ikemura M, et al
    90Y-Labeled Anti-ROBO1 Monoclonal Antibody Exhibits Antitumor Activity against Small Cell Lung Cancer Xenografts.
    PLoS One. 2015;10:e0125468.
    PubMed     Text format     Abstract available


  177. MAH V, Alavi M, Marquez-Garban DC, Maresh EL, et al
    Ribonucleotide reductase subunit m2 predicts survival in subgroups of patients with non-small cell lung carcinoma: effects of gender and smoking status.
    PLoS One. 2015;10:e0127600.
    PubMed     Text format     Abstract available


  178. YU Z, Lu H, Si H, Liu S, et al
    A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.
    PLoS One. 2015;10:e0125517.
    PubMed     Text format     Abstract available


  179. CHEN X, Wang X, He H, Liu Z, et al
    Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
    PLoS One. 2015;10:e0126276.
    PubMed     Text format     Abstract available


  180. NIU PG, Zhang YX, Shi DH, Liu Y, et al
    Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR Activity.
    PLoS One. 2015;10:e0127778.
    PubMed     Text format     Abstract available



  181. Correction: Changes in the Pulmonary Function Test after Radioactive Iodine Treatment in Patients with Pulmonary Metastases of Differentiated Thyroid Cancer.
    PLoS One. 2015;10:e0130220.
    PubMed     Text format     Abstract available


  182. SHENG J, Yang Y, Ma Y, Yang B, et al
    The efficacy of combining antiangiogenic agents with chemotherapy for patients with advanced non-small cell lung cancer who failed first-line chemotherapy: a systematic review and meta-analysis.
    PLoS One. 2015;10:e0127306.
    PubMed     Text format     Abstract available


  183. LAMY PJ, Plassot C, Pujol JL
    Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0128836.
    PubMed     Text format     Abstract available


  184. PARK SL, Carmella SG, Chen M, Patel Y, et al
    Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
    PLoS One. 2015;10:e0124841.
    PubMed     Text format     Abstract available


  185. DAI B, Yan S, Lara-Guerra H, Kawashima H, et al
    Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.
    PLoS One. 2015;10:e0123967.
    PubMed     Text format     Abstract available


  186. YANG L, Tang C, Xu B, Wang W, et al
    Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.
    PLoS One. 2015;10:e0128970.
    PubMed     Text format     Abstract available


  187. CHEN L, Yang J, Zheng M, Kong X, et al
    The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer.
    PLoS One. 2015;10:e0128696.
    PubMed     Text format     Abstract available


  188. OTANI H, Yamamoto H, Takaoka M, Sakaguchi M, et al
    TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells.
    PLoS One. 2015;10:e0129838.
    PubMed     Text format     Abstract available


  189. YIN Z, Cui Z, Guan P, Li X, et al
    Interaction between Polymorphisms in Pre-MiRNA Genes and Cooking Oil Fume Exposure on the Risk of Lung Cancer in Chinese Non-Smoking Female Population.
    PLoS One. 2015;10:e0128572.
    PubMed     Text format     Abstract available


  190. WANG Q, Ke J, Song Q, Hu W, et al
    The SNP rs931794 in 15q25.1 Is Associated with Lung Cancer Risk: A Hospital-Based Case-Control Study and Meta-Analysis.
    PLoS One. 2015;10:e0128201.
    PubMed     Text format     Abstract available


  191. ZHAO X, Wang A, Walter V, Patel NM, et al
    Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.
    PLoS One. 2015;10:e0129280.
    PubMed     Text format     Abstract available


  192. FUJITA S, Masago K, Takeshita J, Okuda C, et al
    Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer.
    PLoS One. 2015;10:e0130219.
    PubMed     Text format     Abstract available


  193. ZHANG Q, Zhang Y, Li K, Wang H, et al
    A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD.
    PLoS One. 2015;10:e0129865.
    PubMed     Text format     Abstract available


  194. GAROFALO M, Jeon YJ, Nuovo GJ, Middleton J, et al
    Correction: MiR-34a/c-Dependent PDGFR-alpha/beta Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.
    PLoS One. 2015;10:e0131729.
    PubMed     Text format     Abstract available


  195. ALDONZA MB, Hong JY, Bae SY, Song J, et al
    Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21alpha-Methylmelianodiol in Lung Cancer Cells.
    PLoS One. 2015;10:e0127841.
    PubMed     Text format     Abstract available


  196. MOLATLHEGI RP, Phulukdaree A, Anand K, Gengan RM, et al
    Cytotoxic Effect of a Novel Synthesized Carbazole Compound on A549 Lung Cancer Cell Line.
    PLoS One. 2015;10:e0129874.
    PubMed     Text format     Abstract available


  197. MINE M, Yamaguchi K, Sugiura T, Chigita S, et al
    miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells.
    PLoS One. 2015;10:e0131350.
    PubMed     Text format     Abstract available


  198. HUANG BT, Lu JY, Lin PX, Chen JZ, et al
    Comparison of Two RapidArc Delivery Strategies in Stereotactic Body Radiotherapy of Peripheral Lung Cancer with Flattening Filter Free Beams.
    PLoS One. 2015;10:e0127501.
    PubMed     Text format     Abstract available


  199. YING L, Zhu Z, Xu Z, He T, et al
    Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.
    PLoS One. 2015;10:e0129593.
    PubMed     Text format     Abstract available


  200. WU CC, Huang KF, Yang TY, Li YL, et al
    The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells.
    PLoS One. 2015;10:e0132052.
    PubMed     Text format     Abstract available


  201. XU JL, Jin B, Ren ZH, Lou YQ, et al
    Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
    PLoS One. 2015;10:e0131278.
    PubMed     Text format     Abstract available


  202. GIOPANOU I, Lilis I, Papaleonidopoulos V, Marazioti A, et al
    Comprehensive Evaluation of Nuclear Factor-kappaBeta Expression Patterns in Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0132527.
    PubMed     Text format     Abstract available


  203. METZ S, Ganter C, Lorenzen S, van Marwick S, et al
    Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis.
    PLoS One. 2015;10:e0132386.
    PubMed     Text format     Abstract available


  204. JIANG S, Zou Z, Nie P, Wen R, et al
    Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    PLoS One. 2015;10:e0132880.
    PubMed     Text format     Abstract available


  205. WEN Q, Wang W, Chu S, Luo J, et al
    Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0132190.
    PubMed     Text format     Abstract available


  206. ROTONDA C, Anota A, Mercier M, Bastien B, et al
    Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial.
    PLoS One. 2015;10:e0132568.
    PubMed     Text format     Abstract available


  207. ALDONZA MB, Hong JY, Bae SY, Song J, et al
    Correction: Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21alpha-Methylmelianodiol in Lung Cancer Cells.
    PLoS One. 2015;10:e0133922.
    PubMed     Text format     Abstract available


  208. CHEN KC, Hsieh YS, Tseng YF, Shieh MJ, et al
    Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread.
    PLoS One. 2015;10:e0133230.
    PubMed     Text format     Abstract available


  209. LIS CG, Patel K, Gupta D
    The Relationship between Patient Satisfaction with Service Quality and Survival in Non-Small Cell Lung Cancer - Is Self-Rated Health a Potential Confounder?
    PLoS One. 2015;10:e0134617.
    PubMed     Text format     Abstract available


  210. SU CY, Liu YP, Yang CJ, Lin YF, et al
    Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0133411.
    PubMed     Text format     Abstract available


  211. HAN Y, Jia C, Cong X, Yu F, et al
    Increased Expression of TGFbetaR2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy.
    PLoS One. 2015;10:e0134682.
    PubMed     Text format     Abstract available


  212. KIM J, Sato M, Choi JW, Kim HW, et al
    Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
    PLoS One. 2015;10:e0134842.
    PubMed     Text format     Abstract available


  213. GUST L, Toullec A, Benoit C, Farcy R, et al
    Pulmonary Endogenous Fluorescence Allows the Distinction of Primary Lung Cancer from the Perilesional Lung Parenchyma.
    PLoS One. 2015;10:e0134559.
    PubMed     Text format     Abstract available


  214. LI W, Wang Y, Zhang Q, Tang L, et al
    MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0134220.
    PubMed     Text format     Abstract available


  215. YANG G, Wang XJ, Huang LJ, Zhou YA, et al
    High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy.
    PLoS One. 2015;10:e0135576.
    PubMed     Text format     Abstract available


  216. WANG Z, Zhao Z, Lu J, Chen Z, et al
    A Comparison of the Biological Effects of 125I Seeds Continuous Low-Dose-Rate Radiation and 60Co High-Dose-Rate Gamma Radiation on Non-Small Cell Lung Cancer Cells.
    PLoS One. 2015;10:e0133728.
    PubMed     Text format     Abstract available


  217. PUTRA AC, Eguchi H, Lee KL, Yamane Y, et al
    The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0134496.
    PubMed     Text format     Abstract available


  218. KOGURE Y, Saka H, Oki M, Saito TI, et al
    Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations.
    PLoS One. 2015;10:e0135393.
    PubMed     Text format     Abstract available


  219. NAVANESAN S, Abdul Wahab N, Manickam S, Sim KS, et al
    Leptospermum flavescens Constituent-LF1 Causes Cell Death through the Induction of Cell Cycle Arrest and Apoptosis in Human Lung Carcinoma Cells.
    PLoS One. 2015;10:e0135995.
    PubMed     Text format     Abstract available


  220. CAO H, Dong W, Shen H, Xu J, et al
    Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer.
    PLoS One. 2015;10:e0135844.
    PubMed     Text format     Abstract available


  221. LEE S, Kim JE, Hong SH, Lee AY, et al
    High Inorganic Phosphate Intake Promotes Tumorigenesis at Early Stages in a Mouse Model of Lung Cancer.
    PLoS One. 2015;10:e0135582.
    PubMed     Text format     Abstract available


  222. GAO F, Xiong X, Pan W, Yang X, et al
    A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.
    PLoS One. 2015;10:e0135647.
    PubMed     Text format     Abstract available


  223. NGAMWONG Y, Tangamornsuksan W, Lohitnavy O, Chaiyakunapruk N, et al
    Additive Synergism between Asbestos and Smoking in Lung Cancer Risk: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0135798.
    PubMed     Text format     Abstract available


  224. CHEN YM, Lai CH, Chang HC, Chao TY, et al
    Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    PLoS One. 2015;10:e0136252.
    PubMed     Text format     Abstract available


  225. JIA L, Liu W, Guan L, Lu M, et al
    Inhibition of Calcium-Activated Chloride Channel ANO1/TMEM16A Suppresses Tumor Growth and Invasion in Human Lung Cancer.
    PLoS One. 2015;10:e0136584.
    PubMed     Text format     Abstract available


  226. KILVAER TK, Paulsen EE, Hald SM, Wilsgaard T, et al
    Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer - A Structured Review with Meta-Analysis.
    PLoS One. 2015;10:e0132481.
    PubMed     Text format     Abstract available


  227. BOTTING GM, Rastogi I, Chhabra G, Nlend M, et al
    Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0136155.
    PubMed     Text format     Abstract available


  228. WANG Y, Chen J, Ding W, Yan B, et al
    Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger.
    PLoS One. 2015;10:e0136659.
    PubMed     Text format     Abstract available


  229. WANG F, Zhou J, Zhang Y, Wang Y, et al
    The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis.
    PLoS One. 2015;10:e0136889.
    PubMed     Text format     Abstract available


  230. YIN J, Wang Y, Yin H, Chen W, et al
    Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
    PLoS One. 2015;10:e0137076.
    PubMed     Text format     Abstract available


  231. WEI YC, Hu X, Gao Y, Fu Z, et al
    Noninvasive Evaluation of Metabolic Tumor Volume in Lewis Lung Carcinoma Tumor-Bearing C57BL/6 Mice with Micro-PET and the Radiotracers 18F-Alfatide and 18F-FDG: A Comparative Analysis.
    PLoS One. 2015;10:e0136195.
    PubMed     Text format     Abstract available


  232. YANG Y, Park SY, Nguyen TT, Yu YH, et al
    Lichen Secondary Metabolite, Physciosporin, Inhibits Lung Cancer Cell Motility.
    PLoS One. 2015;10:e0137889.
    PubMed     Text format     Abstract available


  233. YAMAMOTO K, Ito S, Hanafusa H, Shimizu K, et al
    Uncovering Direct Targets of MiR-19a Involved in Lung Cancer Progression.
    PLoS One. 2015;10:e0137887.
    PubMed     Text format     Abstract available


  234. MORI S, Usami N, Fukumoto K, Mizuno T, et al
    The Significance of the Prognostic Nutritional Index in Patients with Completely Resected Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0136897.
    PubMed     Text format     Abstract available


  235. MORRIS JK, Wald NJ, Springett AL
    Occupational Exposure to Hydrazine and Subsequent Risk of Lung Cancer: 50-Year Follow-Up.
    PLoS One. 2015;10:e0138884.
    PubMed     Text format     Abstract available


  236. WANG Y, Huang L, Wu S, Jia Y, et al
    Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0139285.
    PubMed     Text format     Abstract available


  237. YANG Z, Zan Y, Zheng X, Hai W, et al
    Dynamic FDG-PET Imaging to Differentiate Malignancies from Inflammation in Subcutaneous and In Situ Mouse Model for Non-Small Cell Lung Carcinoma (NSCLC).
    PLoS One. 2015;10:e0139089.
    PubMed     Text format     Abstract available


  238. PENDER A, Garcia-Murillas I, Rana S, Cutts RJ, et al
    Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach.
    PLoS One. 2015;10:e0139074.
    PubMed     Text format     Abstract available


  239. BANAT GA, Tretyn A, Pullamsetti SS, Wilhelm J, et al
    Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma.
    PLoS One. 2015;10:e0139073.
    PubMed     Text format     Abstract available


  240. CHIANG JK, Kao YH, Lai NS
    The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan.
    PLoS One. 2015;10:e0138773.
    PubMed     Text format     Abstract available


  241. WANG H, Zhao X, Guo C, Ren D, et al
    Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells.
    PLoS One. 2015;10:e0139136.
    PubMed     Text format     Abstract available


  242. OKITA R, Wolf D, Yasuda K, Maeda A, et al
    Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells.
    PLoS One. 2015;10:e0139809.
    PubMed     Text format     Abstract available


  243. GHOSE S, Min Y, Lin PC
    delta-Catenin activates Rho GTPase, promotes lymphangiogenesis and growth of tumor metastases.
    PLoS One. 2015;10:e0116338.
    PubMed     Text format     Abstract available


  244. ARSHAD A, Deutsch E, Vozenin MC
    Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration.
    PLoS One. 2015;10:e0115447.
    PubMed     Text format     Abstract available


  245. LEE SY, Choi JE, Jeon HS, Choi YY, et al
    A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection.
    PLoS One. 2015;10:e0140216.
    PubMed     Text format     Abstract available


  246. OZAWA Y, Abe T, Omae M, Matsui T, et al
    Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer.
    PLoS One. 2015;10:e0140437.
    PubMed     Text format     Abstract available


  247. FENG S, Wang Y, Cai K, Wu H, et al
    Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.
    PLoS One. 2015;10:e0140794.
    PubMed     Text format     Abstract available


  248. CEDRES S, Ponce-Aix S, Zugazagoitia J, Sansano I, et al
    Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).
    PLoS One. 2015;10:e0121071.
    PubMed     Text format     Abstract available


  249. LIU LL, Li F, Pao W, Michor F, et al
    Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients.
    PLoS One. 2015;10:e0141665.
    PubMed     Text format     Abstract available


  250. CLARKE N, Biscocho J, Kwei KA, Davidson JM, et al
    Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0142061.
    PubMed     Text format     Abstract available


  251. LIM JU, Yeo CD, Rhee CK, Kim YH, et al
    Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations.
    PLoS One. 2015;10:e0142306.
    PubMed     Text format     Abstract available


  252. CHEN CH, Liao WC, Wu BR, Chen CY, et al
    Endobronchial Ultrasound Changed the World of Lung Cancer Patients: A 11-Year Institutional Experience.
    PLoS One. 2015;10:e0142336.
    PubMed     Text format     Abstract available


  253. MORENO P, Lara-Chica M, Soler-Torronteras R, Caro T, et al
    The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
    PLoS One. 2015;10:e0143376.
    PubMed     Text format     Abstract available


  254. GOZZARD P, Chapman C, Vincent A, Lang B, et al
    Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
    PLoS One. 2015;10:e0143558.
    PubMed     Text format     Abstract available


  255. HU X, Zhang L, Shi Y, Zhou C, et al
    The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
    PLoS One. 2015;10:e0142500.
    PubMed     Text format     Abstract available


  256. SHI Y, Li J, Zhang S, Wang M, et al
    Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study.
    PLoS One. 2015;10:e0143515.
    PubMed     Text format     Abstract available


  257. WEN SW, Everitt SJ, Bedo J, Chabrot M, et al
    Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy.
    PLoS One. 2015;10:e0142608.
    PubMed     Text format     Abstract available


  258. ZHAN W, Han T, Zhang C, Xie C, et al
    TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
    PLoS One. 2015;10:e0142596.
    PubMed     Text format     Abstract available


  259. MING X, Feng Y, Liu H, Zhang Y, et al
    Cardiac Exposure in the Dynamic Conformal Arc Therapy, Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy of Lung Cancer.
    PLoS One. 2015;10:e0144211.
    PubMed     Text format     Abstract available


  260. ADETIBA E, Olugbara OO
    Improved Classification of Lung Cancer Using Radial Basis Function Neural Network with Affine Transforms of Voss Representation.
    PLoS One. 2015;10:e0143542.
    PubMed     Text format     Abstract available


  261. SASI SP, Bae S, Song J, Perepletchikov A, et al
    Correction: Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants.
    PLoS One. 2015;10:e0144213.
    PubMed     Text format     Abstract available


  262. FISCELLA K, Winters P, Farah S, Sanders M, et al
    Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics?
    PLoS One. 2015;10:e0143789.
    PubMed     Text format     Abstract available


  263. JIN Y, Liu Y, Zhang J, Huang W, et al
    The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer.
    PLoS One. 2015;10:e0144187.
    PubMed     Text format     Abstract available


  264. ZHANG Y, Feng Y, Ahmad M, Ming X, et al
    Intermediate Megavoltage Photon Beams for Improved Lung Cancer Treatments.
    PLoS One. 2015;10:e0145117.
    PubMed     Text format     Abstract available


  265. ORLHAC F, Soussan M, Chouahnia K, Martinod E, et al
    18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0145063.
    PubMed     Text format     Abstract available


  266. SUN H, Hu P, Shen H, Dong W, et al
    Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
    PLoS One. 2015;10:e0144663.
    PubMed     Text format     Abstract available


  267. TSAI JR, Liu PL, Chen YH, Chou SH, et al
    Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-kappab/MMPs Signaling Pathway.
    PLoS One. 2015;10:e0144462.
    PubMed     Text format     Abstract available


  268. KANG JI, Hong JY, Lee HJ, Bae SY, et al
    Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    PLoS One. 2015;10:e0144368.
    PubMed     Text format     Abstract available


  269. DELAHAYE-SOURDEIX M, Oliver J, Timofeeva MN, Gaborieau V, et al
    The 12p13.33/RAD52 locus and genetic susceptibility to squamous cell cancers of upper aerodigestive tract.
    PLoS One. 2015;10:e0117639.
    PubMed     Text format     Abstract available


  270. HSU KH, Ho CC, Hsia TC, Tseng JS, et al
    Identification of five driver gene mutations in patients with treatment-naive lung adenocarcinoma in Taiwan.
    PLoS One. 2015;10:e0120852.
    PubMed     Text format     Abstract available


  271. KOCARNIK JM, Park SL, Han J, Dumitrescu L, et al
    Pleiotropic and Sex-Specific Effects of Cancer GWAS SNPs on Melanoma Risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.
    PLoS One. 2015;10:e0120491.
    PubMed     Text format     Abstract available


  272. SILVA IT, Carvalho A, Lang KL, Dudek SE, et al
    In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B.
    PLoS One. 2015;10:e0117794.
    PubMed     Text format     Abstract available


  273. SRIRAM N, Mills J, Lang E, Dickson HK, et al
    Attitudes and Stereotypes in Lung Cancer versus Breast Cancer.
    PLoS One. 2015;10:e0145715.
    PubMed     Text format     Abstract available


  274. PHILLIPS M, Bauer TL, Cataneo RN, Lebauer C, et al
    Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
    PLoS One. 2015;10:e0142484.
    PubMed     Text format     Abstract available


  275. HYUN SH, Lee KH, Choi JY, Kim BT, et al
    Influence of Body Mass Index on the Prognostic Value of Tumor (1)(8)F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0145020.
    PubMed     Text format     Abstract available


  276. MULLAPUDI N, Ye B, Suzuki M, Fazzari M, et al
    Genome Wide Methylome Alterations in Lung Cancer.
    PLoS One. 2015;10:e0143826.
    PubMed     Text format     Abstract available


  277. MORRISON A, Chekaluk Y, Bacares R, Ladanyi M, et al
    BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
    PLoS One. 2015;10:e0119224.
    PubMed     Text format     Abstract available


  278. CHIANG Y, Yang JC, Hsu FM, Chen YH, et al
    The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.
    PLoS One. 2015;10:e0145936.
    PubMed     Text format     Abstract available


  279. CHATTOPADHYAY N, Berger AJ, Koenig E, Bannerman B, et al
    KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
    PLoS One. 2015;10:e0144825.
    PubMed     Text format     Abstract available


  280. MCKAY AJ, Patel RK, Majeed A
    Strategies for tobacco control in India: a systematic review.
    PLoS One. 2015;10:e0122610.
    PubMed     Text format     Abstract available


  281. CAO L, Tong H, Xu G, Liu P, et al
    Systemic lupus erythematous and malignancy risk: a meta-analysis.
    PLoS One. 2015;10:e0122964.
    PubMed     Text format     Abstract available


  282. MISHRA EK, Corcoran JP, Hallifax RJ, Stradling J, et al
    Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
    PLoS One. 2015;10:e0123798.
    PubMed     Text format     Abstract available


  283. CHIEN CH, Lee MJ, Liou HC, Liou HH, et al
    Local Immunosuppressive Microenvironment Enhances Migration of Melanoma Cells to Lungs in DJ-1 Knockout Mice.
    PLoS One. 2015;10:e0115827.
    PubMed     Text format     Abstract available


  284. SHAN L, Lian F, Guo L, Qiu T, et al
    Detection of ROS1 gene rearrangement in lung adenocarcinoma: comparison of IHC, FISH and real-time RT-PCR.
    PLoS One. 2015;10:e0120422.
    PubMed     Text format     Abstract available


  285. GROVE O, Berglund AE, Schabath MB, Aerts HJ, et al
    Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma.
    PLoS One. 2015;10:e0118261.
    PubMed     Text format     Abstract available


  286. HUANG AH, Pan SH, Chang WH, Hong QS, et al
    PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma.
    PLoS One. 2015;10:e0118530.
    PubMed     Text format     Abstract available


  287. TSAY JC, Li Z, Yie TA, Wu F, et al
    Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.
    PLoS One. 2015;10:e0118132.
    PubMed     Text format     Abstract available


  288. REDANIEL MT, Martin RM, Ridd MJ, Wade J, et al
    Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the clinical practice research datalink.
    PLoS One. 2015;10:e0126608.
    PubMed     Text format     Abstract available


  289. PASDAR EA, Smits M, Stapelberg M, Bajzikova M, et al
    Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.
    PLoS One. 2015;10:e0119549.
    PubMed     Text format     Abstract available


  290. PENG H, Ma J, Bai Y, Lu J, et al
    MeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set Analysis.
    PLoS One. 2015;10:e0124620.
    PubMed     Text format     Abstract available


  291. ANOTA A, Mouillet G, Trouilloud I, Dupont-Gossart AC, et al
    Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
    PLoS One. 2015;10:e0125350.
    PubMed     Text format     Abstract available


  292. CHU HL, Yip BS, Chen KH, Yu HY, et al
    Novel antimicrobial peptides with high anticancer activity and selectivity.
    PLoS One. 2015;10:e0126390.
    PubMed     Text format     Abstract available


  293. CAPPELLESSO R, Millioni R, Arrigoni G, Simonato F, et al
    Lumican is overexpressed in lung adenocarcinoma pleural effusions.
    PLoS One. 2015;10:e0126458.
    PubMed     Text format     Abstract available


  294. JAIN A, Lim C, Gan EM, Ng DZ, et al
    Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    PLoS One. 2015;10:e0123587.
    PubMed     Text format     Abstract available


  295. KAMOMAE T, Monzen H, Nakayama S, Mizote R, et al
    Accuracy of image guidance using free-breathing cone-beam computed tomography for stereotactic lung radiotherapy.
    PLoS One. 2015;10:e0126152.
    PubMed     Text format     Abstract available


  296. D'ARCANGELO M, Todaro M, Salvini J, Benfante A, et al
    Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study.
    PLoS One. 2015;10:e0125037.
    PubMed     Text format     Abstract available


  297. MISIC VV, Chan TC
    The perils of adapting to dose errors in radiation therapy.
    PLoS One. 2015;10:e0125335.
    PubMed     Text format     Abstract available


  298. CUNNIFF B, Newick K, Nelson KJ, Wozniak AN, et al
    Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma.
    PLoS One. 2015;10:e0127310.
    PubMed     Text format     Abstract available


  299. PENA N, Carrillo D, Munoz JP, Chnaiderman J, et al
    Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.
    PLoS One. 2015;10:e0123029.
    PubMed     Text format     Abstract available


  300. HECHT SS, Koh WP, Wang R, Chen M, et al
    Elevated levels of mercapturic acids of acrolein and crotonaldehyde in the urine of Chinese women in Singapore who regularly cook at home.
    PLoS One. 2015;10:e0120023.
    PubMed     Text format     Abstract available


  301. SCHWEIGER T, Nikolowsky C, Starlinger P, Traxler D, et al
    Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
    PLoS One. 2015;10:e0120724.
    PubMed     Text format     Abstract available


  302. LIU L, Zhan P, Zhou X, Song Y, et al
    Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.
    PLoS One. 2015;10:e0117032.
    PubMed     Text format     Abstract available


  303. LIU J, Wan L, Lu K, Sun M, et al
    The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    PLoS One. 2015;10:e0114586.
    PubMed     Text format     Abstract available


  304. LIN H, Kou B, Li X, Wang Y, et al
    Grating-based phase-contrast imaging of tumor angiogenesis in lung metastases.
    PLoS One. 2015;10:e0121438.
    PubMed     Text format     Abstract available


  305. ZANDVAKILI I, Davis AK, Hu G, Zheng Y, et al
    Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.
    PLoS One. 2015;10:e0127923.
    PubMed     Text format     Abstract available


  306. ZOLLNER S, Sokolnikov ME, Eidemuller M
    Beyond two-stage models for lung carcinogenesis in the Mayak workers: implications for plutonium risk.
    PLoS One. 2015;10:e0126238.
    PubMed     Text format     Abstract available


  307. FIGEAC F, Dagouassat M, Mahrouf-Yorgov M, Le Gouvello S, et al
    Lung fibroblasts share mesenchymal stem cell features which are altered in chronic obstructive pulmonary disease via the overactivation of the Hedgehog signaling pathway.
    PLoS One. 2015;10:e0121579.
    PubMed     Text format     Abstract available


  308. KLAMMER M, Dybowski JN, Hoffmann D, Schaab C, et al
    Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib.
    PLoS One. 2015;10:e0128542.
    PubMed     Text format     Abstract available


  309. PATTERSON SD, Rossi JM, Paweletz KL, Fitzpatrick VD, et al
    Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.
    PLoS One. 2015;10:e0122149.
    PubMed     Text format     Abstract available


  310. AMARAL FE, Parker D, Randis TM, Kulkarni R, et al
    Rational Manipulation of mRNA Folding Free Energy Allows Rheostat Control of Pneumolysin Production by Streptococcus pneumoniae.
    PLoS One. 2015;10:e0119823.
    PubMed     Text format     Abstract available


  311. DURRANS A, Gao D, Gupta R, Fischer KR, et al
    Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC.
    PLoS One. 2015;10:e0129123.
    PubMed     Text format     Abstract available


  312. PETERSON SW, Jurjevic Z, Frisvad JC
    Expanding the species and chemical diversity of Penicillium section Cinnamopurpurea.
    PLoS One. 2015;10:e0121987.
    PubMed     Text format     Abstract available


  313. ZHAO J, Ji G, Qiang Y, Han X, et al
    A New Method of Detecting Pulmonary Nodules with PET/CT Based on an Improved Watershed Algorithm.
    PLoS One. 2015;10:e0123694.
    PubMed     Text format     Abstract available


  314. YANG Y, Zhao Q, Cai Z, Cheng G, et al
    Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin.
    PLoS One. 2015;10:e0125132.
    PubMed     Text format     Abstract available


  315. HOOGENDAM JP, Zweemer RP, Verkooijen HM, de Jong PA, et al
    No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients.
    PLoS One. 2015;10:e0131899.
    PubMed     Text format     Abstract available


  316. SATO M, Matsubara T, Adachi J, Hashimoto Y, et al
    Differential Proteome Analysis Identifies TGF-beta-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model.
    PLoS One. 2015;10:e0126483.
    PubMed     Text format     Abstract available


  317. CARBOGNIN L, Pilotto S, Milella M, Vaccaro V, et al
    Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
    PLoS One. 2015;10:e0130142.
    PubMed     Text format     Abstract available


  318. HUANG JY, Jian ZH, Ndi Nfor O, Jhang KM, et al
    The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    PLoS One. 2015;10:e0133367.
    PubMed     Text format     Abstract available


  319. IWASE S, Kawaguchi T, Tokoro A, Yamada K, et al
    Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09).
    PLoS One. 2015;10:e0134022.
    PubMed     Text format     Abstract available


  320. MARKOV OV, Mironova NL, Sennikov SV, Vlassov VV, et al
    Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
    PLoS One. 2015;10:e0136911.
    PubMed     Text format     Abstract available


  321. MAHESWARAN E, Pedersen CB, Ditzel HJ, Gjerstorff MF, et al
    Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer.
    PLoS One. 2015;10:e0134967.
    PubMed     Text format     Abstract available


  322. HU K, Tang X, Tang G, Yao S, et al
    18F-FP-PEG2-beta-Glu-RGD2: A Symmetric Integrin alphavbeta3-Targeting Radiotracer for Tumor PET Imaging.
    PLoS One. 2015;10:e0138675.
    PubMed     Text format     Abstract available


  323. CALDERON LE, Liu S, Arnold N, Breakall B, et al
    Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration.
    PLoS One. 2015;10:e0143277.
    PubMed     Text format     Abstract available


  324. STAVRINOU P, Mavrogiorgou MC, Polyzoidis K, Kreft-Kerekes V, et al
    Expression Profile of Genes Related to Drug Metabolism in Human Brain Tumors.
    PLoS One. 2015;10:e0143285.
    PubMed     Text format     Abstract available


  325. ZHANG L, Wu C, Hoffman RM
    Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells.
    PLoS One. 2015;10:e0140721.
    PubMed     Text format     Abstract available


  326. MIN K, Ji B, Zhao M, Ji T, et al
    Development of a Radiolabeled Peptide-Based Probe Targeting MT1-MMP for Breast Cancer Detection.
    PLoS One. 2015;10:e0139471.
    PubMed     Text format     Abstract available


    January 2014
  327. SASPORTAS LS, Hori SS, Pratx G, Gambhir SS, et al
    Detection and quantitation of circulating tumor cell dynamics by bioluminescence imaging in an orthotopic mammary carcinoma model.
    PLoS One. 2014;9:e105079.
    PubMed     Text format     Abstract available


  328. MICUCCI C, Orciari S, Catalano A
    Hyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification.
    PLoS One. 2014;9:e105550.
    PubMed     Text format     Abstract available


  329. MENHOFER MH, Kubisch R, Schreiner L, Zorn M, et al
    The Actin Targeting Compound Chondramide Inhibits Breast Cancer Metastasis via Reduction of Cellular Contractility.
    PLoS One. 2014;9:e112542.
    PubMed     Text format     Abstract available


  330. GEBAUER F, Wicklein D, Horst J, Sundermann P, et al
    Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer.
    PLoS One. 2014;9:e113023.
    PubMed     Text format     Abstract available


  331. RAHIM S, Minas T, Hong SH, Justvig S, et al
    A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model.
    PLoS One. 2014;9:e114260.
    PubMed     Text format     Abstract available


  332. TANGE S, Oktyabri D, Terashima M, Ishimura A, et al
    JARID2 Is Involved in Transforming Growth Factor-Beta-Induced Epithelial-Mesenchymal Transition of Lung and Colon Cancer Cell Lines.
    PLoS One. 2014;9:e115684.
    PubMed     Text format     Abstract available


  333. ZHOU Y, Rideout WM 3rd, Bressel A, Yalavarthi S, et al
    Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy.
    PLoS One. 2014;9:e105886.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: